Drug-Related Hypersensitivity Reactions Leading to Emergency Department: Original Data and Systematic Review.

anaphylaxis drug allergy emergency department hospitalization hypersensitivity pharmacovigilance

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 May 2022
Historique:
received: 31 03 2022
revised: 02 05 2022
accepted: 13 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

The aim of the present study is to describe pharmacological characteristics of drug-related allergies and anaphylaxis leading to the emergency department (ED). An 8-year post hoc analysis on the MEREAFaPS Study database was performed (2012−2019). Subjects who experienced drug-related hypersensitivity leading to an ED visit were selected. Logistic regression analyses were used to estimate the reporting odds ratios (RORs) of drug-related allergies and anaphylaxis adjusting for sex, age classes, and ethnicity. In addition, a systematic review of observational studies evaluating drug-related hypersensitivity reactions leading to ED visits in outpatients was performed. Out of 94,073 ED visits, 14.4% cases were drug-related allergies and 0.6% were anaphylaxis. Females accounted for 56%. Multivariate logistic regression showed a higher risk of drug-related allergy among males and all age classes < 65 years, while a higher risk of anaphylaxis was observed for females (ROR 1.20 [1.01−1.42]) and adults (ROR 2.63 [2.21−3.14]). The systematic review included 37 studies. ED visits related to allergy and anaphylaxis ranged from 0.004% to 88%, and drug-related allergies and anaphylaxis ranged from 0.007% to 88%. Both in our analysis and in primary studies, antibacterials, analgesics, and radiocontrast agents were identified as the most common triggers of hypersensitivity.

Identifiants

pubmed: 35628936
pii: jcm11102811
doi: 10.3390/jcm11102811
pmc: PMC9143688
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Medicines Agency
ID : DGRT 790/2016 All. C.

Références

Pharmaceuticals (Basel). 2021 Jul 15;14(7):
pubmed: 34358104
J Antimicrob Chemother. 2020 Jan 1;75(1):229-235
pubmed: 31637446
Lancet. 2000 Oct 7;356(9237):1255-9
pubmed: 11072960
Clin Exp Allergy. 2017 Sep;47(9):1108-1114
pubmed: 28856836
Pediatr Emerg Care. 2010 Feb;26(2):71-6
pubmed: 20094000
Am J Health Syst Pharm. 1996 Jun 15;53(12):1422-6
pubmed: 8781688
Ann Emerg Med. 2005 Feb;45(2):197-206
pubmed: 15671977
Front Pharmacol. 2021 Jan 29;11:611102
pubmed: 33708120
J Allergy Clin Immunol. 2011 Sep;128(3):594-600.e1
pubmed: 21714994
Eur J Intern Med. 2014 Feb;25(2):147-50
pubmed: 24275113
Intern Emerg Med. 2020 Oct;15(7):1291-1302
pubmed: 32333265
Front Pharmacol. 2020 Apr 06;11:412
pubmed: 32327995
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1169-1176
pubmed: 31786255
Ann Allergy Asthma Immunol. 1997 Mar;78(3):293-6
pubmed: 9087155
N Engl J Med. 2001 Sep 13;345(11):804-9
pubmed: 11556301
Allergy. 1997 Jan;52(1):89-93
pubmed: 9062634
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Br J Clin Pharmacol. 2011 May;71(5):684-700
pubmed: 21480948
Allergy. 2008 Nov;63(11):1418-27
pubmed: 18925878
Korean J Intern Med. 2018 Sep;33(5):1008-1015
pubmed: 29277095
JAMA. 2006 Oct 18;296(15):1858-66
pubmed: 17047216
BMC Pharmacol Toxicol. 2018 Apr 16;19(1):16
pubmed: 29661234
Eur Ann Allergy Clin Immunol. 2008 Dec;40(4):122-9
pubmed: 19227647
Medicine (Baltimore). 2019 Jan;98(4):e14114
pubmed: 30681571
Asian Pac J Allergy Immunol. 2020 Mar;38(1):31-39
pubmed: 30447654
Ann Emerg Med. 2015 Oct;66(4):381-9
pubmed: 25820033
Mil Med Res. 2020 Feb 29;7(1):7
pubmed: 32111253
N Engl J Med. 2018 Nov 29;379(22):2176-2177
pubmed: 30485775
Allergol Int. 2018 Jan;67(1):96-102
pubmed: 28602247
J Allergy Clin Immunol. 2019 Sep;144(3):627-633
pubmed: 31229269
Clin Exp Allergy. 2015 Jun;45(6):1027-39
pubmed: 25495512
Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):188-95
pubmed: 19116955
J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):384-391
pubmed: 30137509
Allergy. 2018 Jun;73(6):1322-1330
pubmed: 29318637
J Allergy Clin Immunol. 2012 Jan;129(1):162-8.e1-3
pubmed: 22018905
JAMA. 2015 Mar 24-31;313(12):1256-7
pubmed: 25803347
Ann Allergy Asthma Immunol. 2015 Oct;115(4):312-6
pubmed: 26276313
Immun Inflamm Dis. 2018 Mar;6(1):3-12
pubmed: 29094518
Intern Emerg Med. 2021 Apr;16(3):741-748
pubmed: 33392971
Pharmacoepidemiol Drug Saf. 2003 Apr-May;12(3):195-202
pubmed: 12733472
Ann Allergy Asthma Immunol. 2001 Jul;87(1):27-32
pubmed: 11476457
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S126-37
pubmed: 20176256
Int J Clin Pharm. 2018 Oct;40(5):1359-1371
pubmed: 29611015
J Pediatr. 2008 Mar;152(3):416-21
pubmed: 18280852
Int Arch Allergy Immunol. 2014;164(3):246-52
pubmed: 25170673
Emerg Med (Fremantle). 2003 Aug;15(4):341-7
pubmed: 14631701
Am J Emerg Med. 2012 Jun;30(5):826-9
pubmed: 22676922
Allergy. 2016 Apr;71(4):443-62
pubmed: 26678823
Med Lav. 2018 Feb 01;109(1):68-76
pubmed: 29411737
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):60
pubmed: 30275849
Wien Klin Wochenschr. 2019 Jul;131(13-14):329-336
pubmed: 31037361
Public Health Rep. 2011 May-Jun;126(3):312-7
pubmed: 21553658
Ann Allergy Asthma Immunol. 2018 Dec;121(6):717-721.e1
pubmed: 30189249
Int Arch Allergy Immunol. 2018;175(1-2):91-98
pubmed: 29301119
Clin Infect Dis. 2008 Sep 15;47(6):735-43
pubmed: 18694344
Clin Exp Immunol. 2008 Sep;153 Suppl 1:7-11
pubmed: 18721322
Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1099-106
pubmed: 23963962
Asian Pac J Allergy Immunol. 2011 Dec;29(4):307-12
pubmed: 22299309
Eur J Emerg Med. 2015 Aug;22(4):253-9
pubmed: 24841773
Immunol Allergy Clin North Am. 2017 Nov;37(4):629-641
pubmed: 28965631
Ann Allergy Asthma Immunol. 2018 Sep;121(3):348-352
pubmed: 29981442
N Engl J Med. 2011 Nov 24;365(21):2002-12
pubmed: 22111719
Appl Health Econ Health Policy. 2015 Oct;13(5):507-14
pubmed: 25854901
J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1002-1009.e2
pubmed: 28941671
Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):321-9
pubmed: 18596589
Allergy Asthma Clin Immunol. 2016 Dec 13;12:67
pubmed: 27999603
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):46-51
pubmed: 24565768
Pediatrics. 2019 Mar;143(3):
pubmed: 30765462
Allergy Asthma Proc. 2019 Jan 1;40(1):41-47
pubmed: 30582495
J Allergy Clin Immunol Pract. 2019 Jan;7(1):112-113
pubmed: 30598173
J Allergy Clin Immunol. 2014 Dec;134(6):1318-1328.e7
pubmed: 25280385
J Allergy Clin Immunol. 2015 Apr;135(4):956-963.e1
pubmed: 25468198
World Allergy Organ J. 2020 Oct 30;13(10):100472
pubmed: 33204386
Int Arch Allergy Immunol. 2020;181(7):481-487
pubmed: 32396909
Am J Health Syst Pharm. 1996 Jun 15;53(12):1416-22
pubmed: 8781687
J Allergy Clin Immunol. 2014 Nov;134(5):1125-30
pubmed: 24985399
Allergy. 2014 Apr;69(4):420-37
pubmed: 24697291

Auteurs

Silvia Pagani (S)

Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy.

Niccolò Lombardi (N)

Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy.

Giada Crescioli (G)

Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy.

Violetta Giuditta Vighi (VG)

Hospital Pharmacy, ASST Vimercate, 20871 Vimercate, Italy.

Giulia Spada (G)

Hospital Pharmacy, ASST Vimercate, 20871 Vimercate, Italy.

Paola Andreetta (P)

Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy.

Annalisa Capuano (A)

Section of Pharmacology "L. Donatelli", Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, 80138 Naples, Italy.

Alfredo Vannacci (A)

Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50139 Florence, Italy.
Tuscan Regional Centre of Pharmacovigilance, 50122 Florence, Italy.

Mauro Venegoni (M)

Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy.
Pharmacology Unit, Department of Diagnostics and Public Health, University of Verona, 37100 Verona, Italy.

Giuseppe Danilo Vighi (GD)

Department of Medicine, ASST Vimercate, 20871 Vimercate, Italy.

Classifications MeSH